CON
Get informed when a big investor buys or sells
+ FollowUndervalued by 64.5% based on the discounted cash flow analysis.
| Market cap | $3.18 Billion |
|---|---|
| Enterprise Value | $3.68 Billion |
| Dividend Yield | $0.25 (1.01%) |
| Earnings per Share | $1.39 |
| Beta | 0.72 |
| Outstanding Shares | 126,647,000 |
| P/E Ratio | 17.7 |
|---|---|
| PEG | 59.48 |
| Price to Sales | 1.9 |
| Price to Book Ratio | 8.25 |
| Enterprise Value to Revenue | 2.17 |
| Enterprise Value to EBIT | 18.36 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 1.32 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 85.27%▼ 3.06% |
|---|---|
| Total Invested | $2.31B▲ 5.14% |
| Investors Holding | 280▲ 18.00% |
No data
This committee works directly with the Finance Committee to analyze and score tax legislation. Its technical expertise and reports directly influence corporate tax policy, which impacts Concentra's financial structure and profitability.
This is a highly influential committee controlling taxation (impacting Concentra's profitability) and entitlement spending (like Medicare/Medicaid), which significantly shapes the broader healthcare reimbursement landscape affecting all healthcare providers.
This committee allocates discretionary federal spending. Any federal contracts Concentra might have (e.g., with DHS, VA, DoD) would be directly funded through the Appropriations process, thus giving committee members direct influence.
This committee directly regulates labor laws (critical for Concentra as an employer and a provider of occupational health services) and has significant influence over broader healthcare policy, directly impacting Concentra's operating environment.